Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

There is a vital need for improved therapeutic strategies that are effective in both primary and metastatic triple-negative breast cancer (TNBC). Current treatment options for TNBC patients are restricted to chemotherapy; however tyrosine kinases are promising druggable targets due to their high exp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Linklater, Erik S., Tovar, Elizabeth A., Essenburg, Curt J., Turner, Lisa, Madaj, Zachary, Winn, Mary E., Melnik, Marianne K., Korkaya, Hasan, Maroun, Christiane R., Christensen, James G., Steensma, Matthew R., Boerner, Julie L., Graveel, Carrie R.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342523/
https://ncbi.nlm.nih.gov/pubmed/27655711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12065
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki